Monthly Archives: April 2022

Women find community in STEM fields at UA – The University of Alabama Crimson White

Posted: April 19, 2022 at 1:56 am

In the fall of her freshman year, Sarah Holdrup, a senior majoring in environmental engineering, received a lower grade than her male lab partner, despite turning in the same lab report. When she met with the professor to question the grade, the professor told her this was something she should expect in a workforce where she would be paid less and be listened to less than her male colleagues.

At The University of Alabama, women make up 20% of the faculty in the College of Engineering and 27% of the faculty in Natural Sciences and Mathematics.

Holdrup didnt let this experience stop her from pursuing her degree, and that spring, she joined the Universitys chapter of the Society of Women Engineers. She is now the president of the organization and recently received the Guiding Star award for her significant contributions to the section and the UA campus.

The organization connected Holdrup with other female engineering majors who shared similar experiences, recommended professors and classes, and encouraged her through challenging classes.

Alina Iliescu, a senior majoring in aerospace engineering, also found a community of women in UA Women in Aeronautics and Astronautics, a professional development organization and a social club that builds a community within the aerospace discipline.

Iliescu said she experienced impostor syndrome, a feeling of not belonging, from being in these difficult classes as a woman.

It was nice having a little support group with people that are going through the same thing, Iliescu said. The social meetings really help the girls get to know each other and make friends within aerospace, because like I said, its kind of hard meeting other women in aerospace.

Katie OHarra, an assistant professor of chemical engineering in the Honors College, said she recognized this gender imbalance during her undergraduate classes at the University from 2013 to 2017. In her four years, she only had two female professors in her science, technology, engineering and mathematics classes.

This bothered her because she knew it didnt reflect the changing engineering student gender demographics. This thought motivated her to teach in graduate school and become a mentor to nine undergraduate chemical engineering majors, eight of whom were women.

If you can go through your entire four-year curriculum and not experience a different perspective or lived experience, that can be kind of frustrating, especially if you want to envision yourself in that role, OHarra said.

Now, OHarra leads the Engineering Positive and Intentional Change Scholars Program. Through the four-year curriculum, honors engineering students learn about the broader impacts of engineering on social justice and the environment.

Just because you dont necessarily see yourself represented there yet doesnt mean thats not the place for you, OHarra said. Sometimes you might be the only woman in the room, but youre there for a reason. You should be there to contribute your unique perspective and experiences that only you can bring to the table.

As the first Black woman in Alabama to earn a doctorate in physics, Shelia Nash-Stevenson often remembers being the only woman in her workroom.

Nash-Stevenson has worked at Marshall Space Flight Center for over 30 years and currently works as a science projects manager. She now works under the first female director of Marshall Space Flight Center, UA alumna Jody Singer.

The glass ceiling has been broken, Nash-Stevenson said. Theres more and more females coming up that are able to take on those responsibilities that have been traditionally male responsibilities. Females are doing a great job at Marshall and at NASA.

According to the U.S. Census, since 1970, the share of women in the science, technology, engineering and math workforces has increased from 8% to 27%.

Jules Bates, a junior majoring in chemical engineering, said she believes the work of these women has impacted her academic journey as a woman in STEM.

The fact that Im not really able to think of anything that has set me back and set me apart from my male peers, it really speaks volumes to the work that has already been put in to make engineering and especially chemical engineering more equal and have more equal opportunities, Bates said.

Bates recently received the Goldwater Scholarship for her research on using stem cells to treat epilepsy.

When I got the Goldwater, this was after I had already been researching for two years, it meant a lot because it was a huge payoff from the work I have been doing, Bates said. It just gave me some inspiration that I am following the goals that I set for myself and I am on the right track.

Nash-Stevenson said she encourages women in STEM to connect with other women, stick together and make sure they succeed.

When I was in school, there were very few females in STEM fields. Those that were, we hung out together, studied together and encouraged each other because we had the same capabilities and sometimes more than our male counterparts, Nash-Stevenson said. People will tell you you cant do it, but its not their decision.

Questions? Email the culture desk at culture@cw.ua.edu.

See the original post here:
Women find community in STEM fields at UA - The University of Alabama Crimson White

Posted in Alabama Stem Cells | Comments Off

Columbus man to be one of first to receive transplant via new OhioHealth program – 10TV

Posted: April 19, 2022 at 1:55 am

Marc Howard was diagnosed with multiple myeloma. He will receive a transplant using his own cells later this year.

COLUMBUS, Ohio It all started with back pain that seemed to be progressively getting worse.

My back, the structure of my body, was like starting to deteriorate, and I could tell, he said. I'm tall, so when I started to lean over, and the pain and things of that nature, I'm like, yo, something's going on.

His longtime love Sonia Grant noticed, too. And she was right there to encourage him to get it checked.

When he did, doctors found holes in his spine where his bone had deteriorated. He had a vertebroplasty procedure to have those holes filled with bone cement. But that was not the end of his journey. In fact, it was really only the beginning.

After the surgery, he was okay for about a month, then I saw him (leaning) over again, and he couldnt get off the bed one day, Grant said. I said, uh uh, were going back up there (to the hospital). Theres something wrong.

And something was. Howard was diagnosed with multiple myeloma, a cancer that forms in the plasma cells.

I dont want to be the woe is me, Howard said. I want to be the success story for somebody, for the world to look at, like, that man went through a situation, and he made it.

And hes making it so far, with the help of Grant. Hes been doing weekly chemotherapy treatments and taking daily medication. Meanwhile, Grant is making sure hes eating his fruits and veggies and drinking plenty of water, too.

If youre not up to the challenge, I will help you get there, I will, Grant said. Because failure is just not a thing when it comes to fighting something like cancer. You gotta fight, you just gotta fight.

This fight will culminate with a major procedure later this fall via OhioHealths new Blood and Marrow Transplant Program. Howard will be one of the first patients to receive an autologous stem cell transplant, meaning the procedure will use his own cells.

Dr. Yvonne Efebera, the medical director for the program, explains this process is different than a procedure using donor cells.

BMT, blood and marrow transplant, is a process where, certain diseases require this, where non-functioning, deficient bone marrow or cancer cells are eliminated by giving high-dose chemotherapy, with or without radiation, and then replaced by new, healthy cells, Dr. Efebera said.

Shes been treating Howard throughout this process and points out that this is one of the benefits of the new program. Before, patients who needed transplants would have to be sent to other healthcare systems. Now, they can go from start to finish with the same clinical team.

Marc always wanted to be the first, she joked. Hes anxious to have his stem cells to be the first collected and the first admitted.

Both Howard and Grant are up to the challenge.

Its a battle, Grant said. Were halfway through the battle, and so, were going to get all the way to the end of the battle. Bruised, not broken. But were in the battle. But were going to get through it.

Read the rest here:
Columbus man to be one of first to receive transplant via new OhioHealth program - 10TV

Posted in Ohio Stem Cells | Comments Off

Biotechnology, M.S. | NYU Tandon School of Engineering

Posted: April 19, 2022 at 1:54 am

Request Information

Biotechnology is a swiftly growing industry. From the food grown at our farms to the medicine we buy and the ways we clean up the environment, biotechnology affects many facets of our daily lives. Major developments in the field occur every day, with many introduced by academic and professional communities before the greater public is even aware of industry advancements.

At the School of Engineering, youll join in these exciting discoveries. Course topics range from industrial application of enzymes and bio-polymer synthesis to modern drug design and the role of biotechnology in health care. The availability of various and varied electives enables you to specialize in selected biotechnology areas.

The program also includes Advanced Cell and Molecular Biology and Genetic Engineering courses, both with labs. Students can further enhance their research and analytical skills by registering for a Guided Study course. Taking two such courses will enable students to complete a body of research work equivalent to a master's thesis (optional). Students can also take a business- or management-related course from Biotechnology and Entrepreneurship M.S.

Other electives are available for both programs. For further details please visitBiotechnolgy, M.S. curriculum belowand theBiotechnology and Entrepreneurship, M.S. curriculum.

With advisors permission students can take courses at other Schools of NYU.

There are ample research/internship opportunities available at NYU and NYC at large. For example, many Biotech M.S. students participate in research projects at the NYU Langone Medical Center, the world-renowned Memorial Sloan Kettering Cancer Center, and other research institutions in the city. There are also internships in Biotech start-ups. All students can, of course, apply for summer internships at big pharmaceutical companies. To learn more about these opportunities see what our students say below.

Find outabout AdmissionRequirements.

What Our Students Say

See the rest here:
Biotechnology, M.S. | NYU Tandon School of Engineering

Posted in Biotechnology | Comments Off

Masters in Biotechnology Program | Georgetown University

Posted: April 19, 2022 at 1:54 am

The MS in Biotechnology program offers track options inBioBusiness,BioScience,Drug Design and Discovery,Entrepreneurship, andIndustrial Sciencesas well as flexibility for anIndividualized Track. We focus on developing leadership skills, teamwork and entrepreneurship that are essential for career success.

A highlight of the program is thecapstone internship, which allows students to gain the desired work experience. Internship opportunities are available in all the tracks that include research in industry, academic, and government laboratories and in business development, marketing, commercialization, finance, regulatory affairs, and technology transfer.

Georgetown Biotech Students & Alumni LinkedIn

If this is your first time hearing about the Georgetown Biotechnology Program, our Information Sessions are a great start for you! The goal of the Information Sessions is to give interested students an overview of the Georgetown Biotechnology Program and to engage in an interactive dialogue with our prospective students who are discovering the next generation of biotechnology. We will be hosting the following webinar(s):

We look forward to meeting you virtually and to hearing your questions about the M.S. in Biotechnology. Please RSVP above.

If you have heard about the Georgetown Biotechnology Program and have been engaged with us during the admission process, Come n Mingle with faculty, alumni, and current students to learn more about our program. We will be hosting the following webinar(s):

If you have a passion for science, health, and biotechnology and would like to explore these subjects in-depth before college, here is your chance to do so with the High School Biotechnology for Science & Health Academy this summer! For more information, visit our website.

The Georgetown Biotechnology Program is thrilled to introduce two new topics to its curriculum: new courses in Vaccine Development and Gene Therapy will cover the most current knowledge and business aspects of their fields. Courses like these will allow our students to become versed in the most cutting-edge technologies and build their skills and expertise towards 21st century needs. Students will learn the scientific, business, and regulatory modalities of vaccine development and gene therapy through these new additions to our program.

Georgetown University will require students, faculty and staff who return to campus this fall to be vaccinated against the coronavirus.

Posted in Biotechnology | Comments Off

Nautilus Biotechnology to Announce First Quarter 2022 …

Posted: April 19, 2022 at 1:54 am

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the first quarter 2022 before market open on Tuesday, May 3rd, 2022.

The companys management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the Investors section of the company website at: http://www.nautilus.bio.

About Nautilus Biotechnology, Inc.

With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit http://www.nautilus.bio.

Contacts

Investors:InvestorRelations@nautilus.bio

Media:Thermal for Nautilus BiotechnologyKaustuva DasPress@nautilus.bio

Original post:
Nautilus Biotechnology to Announce First Quarter 2022 ...

Posted in Biotechnology | Comments Off

Is a Career in Biotech Right for You? – BioSpace

Posted: April 19, 2022 at 1:54 am

If you're thinking about breaking into the biotechnology industry, you might be feeling overwhelmed by all the jobs that are encompassed within that sector. Where do you start your job search? How do you know if you'll be qualified for the biotech position you want? Luckily, we have done the research for you and put together a guide to help you decide where to go within the biotech field.

We will cover the wide range of jobs you could have while working in the biotech industry. We'll also discuss what type of background is best for switching to the industry and what level of education you should complete before applying to most positions.

Keep in mind that there are always exceptions you might be surprised by the ways that skills from other careers might transfer over and still be useful within the biotechnology industry.

What Are Biotechnology Jobs?

Biotechnology is a branch of biology that involves utilizing natural, biological processes for the purpose of benefiting mankind. In other words, it's the use of various techniques, like genetic manipulation and DNA sequencing, to understand more about biology and create a product that can be used to help others.

There are many different types of jobs that fall under the biotech umbrella. Biotechnology, as a practice, works its way into many fields of science as it relates to animals, humans, food safety and more. Biotechnology understanding can be applied to health and medical sciences, biomedical engineering, agriculture, immunology, virology and more.

Most biotechnology positions involve working in research or product development labs. Depending on your area of expertise, you could research living organisms and use technology to chart and expand upon your findings. In general, that research is used to create products that can help others within the field, whether it's discovering new medicine, creating standards for chemistry, understanding water quality goals, advancing biology understandings or contributing to ongoing research.

Aside from research, there are also several technician roles and technical support positions available within multiple fields that utilize biotechnology understanding. If you're unsure about where to begin in your biotech job search, it's best to search using an industry-specific job board.

Some examples of job areas in biotech include:

Though you can secure these jobs with a biotechnology degree from an accredited university, that is not the only path you can take. You can just as easily transfer to the biotechnology field from different careers. With education, understanding and practice, you can work in practically any field you want, regardless of your background.

What Qualifications Do I Need To Work In Biotechnology?

As stated above, most biotechnology jobs rely heavily on research and analysis. No matter what your background is, you'll need to have demonstrable research and analysis skills that you can lean on for a job in biotech.

With research skills also comes an understanding of the industry and an understanding of the topics being researched. Critical thinking, observation and technical skills are also very important for anyone working in biotech. Also, experience working in a laboratory in any capacity will hold some weight when applying for biotech positions since you'd likely be working in a lab in that career.

On top of those skills, many biotech recruitersexpect their applicants to have a Bachelor's degree in biotechnology or a related field, like biology, chemistry or natural sciences. Some positions, like those in the agricultural and food science fields, may accept an Associate's Degree instead. Some will also consider applicants who have certificates in biotechnology.

Professionals who work in advanced scientist positions will often have a Master's or Ph.D in the topic of the field they are covering. People who have worked in the field at length will commonly move to a manager or postsecondary teaching position later in their career.

Which Industries Are Best For A Career Change To Biotechnology?

Changing careers from a different field to biotechnology may seem daunting, but it is definitely possible.

The best careers to work in before switching to biotechnology are any that are already within a scientific field. Being able to prove and show examples of your understanding of working within a scientific lab or research facility will make you a more marketable candidate for biotechnology positions.

Careers with a heavy technology background, like computer system analysts, programmers and developers, might also have a good chance of switching to biotech because they have already mastered an understanding of data collection and analysis.

Working in healthcare in any capacity requires an understanding of biology and the way it relates to our everyday lives. This type of understanding will look good to biotech recruiters because biology is at the heart of all biotech positions. Similarly, careers in math or physics transfer well to biotech positions.

Professionals working in communication roles may also have a potential job within the biotech industry because there is always a need for written reports of study findings and explanations of that analysis. With the way biotech is expanding, communicating findings to the general public is more important than ever, especially considering that all parts of biotechnology have the goal of enhancing a community's lives in one way or another.

The Bureau of Labor Statistics published data that shows biotechnology is a growing field with some of the most competitive wages and compensation in the country. Our society is becoming more and more reliant on biological advancements and there will always be a need in the field for more researchers and experts.

In Conclusion

Switching from your career path to something entirely different like biotechnology may seem impossible, but it's not. Individuals with the right set of skills and a relatable background will be able to find a position in the biotech field if they are consistent in searching for it.

No matter what your background is or how old you are, you can learn new skills and take individual classes to learn more about research, analysis and how biotechnology relates to your life or the subject you hope to study. There are countless jobs, many of which people don't know about, within biotechnology that are open or will be open in the near future as the field continues to expand.

Link:
Is a Career in Biotech Right for You? - BioSpace

Posted in Biotechnology | Comments Off

Biotechnology Reagents Market 2022 Detailed Analysis of top Ventures with Regional Outlook | Life Technologies, (US), Bio-Rad (US), Thermo Fisher…

Posted: April 19, 2022 at 1:54 am

Overview Of Biotechnology Reagents Market Insights 2022

The Biotechnology Reagents Market 2022 report provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current situation of the market size, share, demand, development patterns, and forecast in the coming years.

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The report Global Biotechnology Reagents Market analyzes the strategy patterns, and forecast in the coming years. The report evaluates the market size of the Global Biotechnology Reagents Market studies the strategy patterns adopted by the prominent international players.

Request a sample report @: https://globalmarketvision.com/sample_request/123016

Key Competitors of the Global Biotechnology Reagents Market are:

Life Technologies, (U.S.), Bio-Rad (U.S.), Thermo Fisher Scientific (U.S.), Water Corporation (U.S.), Sigma-Aldrich (U.S.), Agilent Technologies Inc. (U.S.), Betcon Dickinson (U.S.), Beckman Coulter (U.S.), Roche (Switzerland), Abbott (U.S.).

Global Biotechnology Reagents Market Segmentation:

Market Segmentation: By Type

Life scienceAnalytical

Market Segmentation: By Application

Protein synthesis and purificationGene expressionDNA and RNA analysisDrug testing

The research report studies the past, present, and future performance of the global market. The report further analyzes the present competitive scenario, prevalent business models, and the likely advancements in offerings by significant players in the coming years.

The report includes company profiles of almost all major players in the Biotechnology Reagents market. The Company Profiles section provides valuable analysis of strengths and weaknesses, business trends, recent advances, mergers and acquisitions, expansion plans, global presence, market presence, and portfolios of products from major market players. This information can be used by players and other market participants to maximize their profitability and streamline their business strategies. Our competitive analysis also provides vital information that will help new entrants identify barriers to entry and gauge the level of competitiveness in the Biotechnology Reagents market.

Regional analysis of Biotechnology Reagents market covers:

COVID-19 Impact

Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biotechnology Reagents Market in 2022.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Reasons for buying this Biotechnology Reagents Market report:

Table of Contents

Global Biotechnology Reagents Market Research Report 2022 2029

Chapter 1 Biotechnology Reagents Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Biotechnology Reagents Market Forecast

Buy Exclusive [emailprotected] https://globalmarketvision.com/checkout/?currency=USD&type=single_user_license&report_id=123016

If you have any special requirements, please let us know and we will offer you the report as you want.

About Global Market Vision

Global Market Vision consists of an ambitious team of young, experienced people who focus on the details and provide the information as per customers needs. Information is vital in the business world, and we specialize in disseminating it. Our experts not only have in-depth expertise, but can also create a comprehensive report to help you develop your own business.

With our reports, you can make important tactical business decisions with the certainty that they are based on accurate and well-founded information. Our experts can dispel any concerns or doubts about our accuracy and help you differentiate between reliable and less reliable reports, reducing the risk of making decisions. We can make your decision-making process more precise and increase the probability of success of your goals.

Sarah Ivans | Business Development

Phone: +1-3105055739

Email: [emailprotected]

Global Market Vision

Website: http://www.globalmarketvision.com

Posted in Biotechnology | Comments Off

Puma Biotechnology, Inc. (NASDAQ:PBYI) Expected to Announce Earnings of -$0.13 Per Share – Defense World

Posted: April 19, 2022 at 1:54 am

Equities research analysts expect Puma Biotechnology, Inc. (NASDAQ:PBYI Get Rating) to report earnings per share (EPS) of ($0.13) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Puma Biotechnologys earnings. Puma Biotechnology posted earnings of $0.40 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 132.5%. The company is expected to report its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that Puma Biotechnology will report full year earnings of $0.16 per share for the current financial year, with EPS estimates ranging from $0.06 to $0.25. For the next financial year, analysts anticipate that the company will report earnings of $0.63 per share, with EPS estimates ranging from $0.35 to $0.91. Zacks Investment Researchs EPS averages are a mean average based on a survey of research firms that follow Puma Biotechnology.

Puma Biotechnology (NASDAQ:PBYI Get Rating) last issued its quarterly earnings results on Thursday, March 3rd. The biopharmaceutical company reported $0.10 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.11) by $0.21. Puma Biotechnology had a negative net margin of 11.49% and a negative return on equity of 357.74%. The company had revenue of $55.40 million during the quarter, compared to analysts expectations of $47.17 million. During the same quarter last year, the company posted ($0.38) EPS. The firms revenue was up 5.3% compared to the same quarter last year.

Large investors have recently bought and sold shares of the stock. Invesco Ltd. grew its holdings in shares of Puma Biotechnology by 18.3% during the second quarter. Invesco Ltd. now owns 12,825 shares of the biopharmaceutical companys stock worth $118,000 after purchasing an additional 1,980 shares during the last quarter. BNP Paribas Arbitrage SA grew its holdings in shares of Puma Biotechnology by 64.4% during the fourth quarter. BNP Paribas Arbitrage SA now owns 11,354 shares of the biopharmaceutical companys stock worth $35,000 after purchasing an additional 4,447 shares during the last quarter. Principal Financial Group Inc. grew its holdings in shares of Puma Biotechnology by 13.2% during the fourth quarter. Principal Financial Group Inc. now owns 50,445 shares of the biopharmaceutical companys stock worth $153,000 after purchasing an additional 5,883 shares during the last quarter. Diversified Trust Co grew its holdings in shares of Puma Biotechnology by 30.8% during the fourth quarter. Diversified Trust Co now owns 25,688 shares of the biopharmaceutical companys stock worth $78,000 after purchasing an additional 6,053 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of Puma Biotechnology by 2.9% during the second quarter. Wells Fargo & Company MN now owns 224,470 shares of the biopharmaceutical companys stock worth $2,062,000 after buying an additional 6,314 shares during the period. 89.99% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ PBYI traded down $0.05 during mid-day trading on Friday, hitting $2.83. The company had a trading volume of 184,197 shares, compared to its average volume of 426,443. The company has a market capitalization of $116.96 million, a PE ratio of -3.93 and a beta of 1.02. Puma Biotechnology has a 1-year low of $2.06 and a 1-year high of $11.95. The businesss 50-day simple moving average is $2.68 and its 200 day simple moving average is $3.48.

About Puma Biotechnology (Get Rating)

Puma Biotechnology, Inc, a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors.

Insights on Rosmarinic Acid Market: Facts, Figures and Trends 2022-2028 by Sabinsa, Shaanxi Yuantai Biological Technology, Natrusolate, ACE…

Posted: April 19, 2022 at 1:53 am

The Research report provides an in-depth analysis of the impact of COVID-19 on numerous segments within the Rosmarinic Acid market-supported product types, applications, and key players like (Sabinsa, Shaanxi Yuantai Biological Technology, Natrusolate, ACE Biotechnology, Yongzhou Huamao Biotechnology, Naturalin Bio-Resources, and more) across various countries around the world. Further, the Rosmarinic Acid market report additionally provides insights into market developments, trends, provide and demand changes across numerous regions across the globe. The market is predicted to witness continuing growth throughout the forecast from 2022 to 2028. It commits various factors affecting industry like market environment, various policies of the government, past data and market trends, technological advancements, upcoming innovations, market risk factors, market restraints, and challenges within the industry. Then it analyzed the worlds main region market conditions, including the demand and supply chain analysis and industry rate of growth etc. At the top, the report introduced a new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Request for Sample Copy of Rosmarinic Acid Market with Complete TOC and Figures & Graphs @ https://www.affluencemarketreports.com/industry-analysis/request-sample/2318611/

Whats Included in Sample Copy of Rosmarinic Acid Market Report:

Further, the report presents profiles of competitors in the Rosmarinic Acid market include:

The report provides an accurate analysis of the changing competitive dynamics. It provides a forward-looking perspective on the various factors that drive or restrict market growth. It provides a five-year forecast evaluated based on Rosmarinic Acid market growth projections. Helps in understanding the key product segments and their future, to gain a complete view of the market, and make informed business decisions by performing an in-depth analysis of the market segments.

Contact for Additional Customization in Rosmarinic Acid Market Report at https://www.affluencemarketreports.com/industry-analysis/request-inquiry/2318611/

Following Key Segments Covered in the Global Rosmarinic Acid Market Report:

Rosmarinic Acid Market Breakdown by Product Type:

Rosmarinic Acid Market Breakdown by Application:

Along with Rosmarinic Acid Market research analysis, buyer also gets valuable information about global Rosmarinic Acid Production and its market share, Revenue, Price and Gross Margin, Supply, Consumption, Export, import volume, and values for the following Regions:

Benefits of Rosmarinic Acid Market Report:

For More Details on the Impact of COVID-19 on Rosmarinic Acid Market, Connect with us at https://www.affluencemarketreports.com/industry-analysis/covid19-request/2318611/

For More Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number:

U.S: +1-(424) 256-1722

U.K.: +44 1158 88 1333

Email: [emailprotected]

Website: http://www.affluencemarketreports.com

Visit link:
Insights on Rosmarinic Acid Market: Facts, Figures and Trends 2022-2028 by Sabinsa, Shaanxi Yuantai Biological Technology, Natrusolate, ACE...

Posted in Biotechnology | Comments Off

Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit

Posted: April 19, 2022 at 1:53 am

LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi's executive team will participate at the Jefferies “Biotech on the Bay” Summit, to be held in-person in Miami, FL April 26-27, 2022.

Read the original post:
Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit

Posted in Global News Feed | Comments Off

Monthly Archives: April 2022

Women find community in STEM fields at UA – The University of Alabama Crimson White

Columbus man to be one of first to receive transplant via new OhioHealth program – 10TV

Biotechnology, M.S. | NYU Tandon School of Engineering

Masters in Biotechnology Program | Georgetown University

Nautilus Biotechnology to Announce First Quarter 2022 …

Is a Career in Biotech Right for You? – BioSpace

Biotechnology Reagents Market 2022 Detailed Analysis of top Ventures with Regional Outlook | Life Technologies, (US), Bio-Rad (US), Thermo Fisher…

Puma Biotechnology, Inc. (NASDAQ:PBYI) Expected to Announce Earnings of -$0.13 Per Share – Defense World

Insights on Rosmarinic Acid Market: Facts, Figures and Trends 2022-2028 by Sabinsa, Shaanxi Yuantai Biological Technology, Natrusolate, ACE…

Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit

Categories

Archives

Recommended Sites

Contact Us

Recent Posts